0001209191-18-057930.txt : 20181109
0001209191-18-057930.hdr.sgml : 20181109
20181109160245
ACCESSION NUMBER: 0001209191-18-057930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181107
FILED AS OF DATE: 20181109
DATE AS OF CHANGE: 20181109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pla Frederic
CENTRAL INDEX KEY: 0001649167
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 181173063
MAIL ADDRESS:
STREET 1: C/O GENOMIC HEALTH, INC.
STREET 2: 101 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063-4700
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-07
0
0001131324
GENOMIC HEALTH INC
GHDX
0001649167
Pla Frederic
301 PENOBSCOT DR.
REDWOOD CITY
CA
94063
0
1
0
0
COO
Common Stock
2018-11-07
4
M
0
36633
27.00
A
72171
D
Common Stock
2018-11-07
4
M
0
6867
27.48
A
79038
D
Common Stock
2018-11-07
4
S
0
2100
80.8571
D
76938
D
Common Stock
2018-11-07
4
S
0
700
81.4368
D
76238
D
Common Stock
2018-11-07
4
S
0
3657
82.8731
D
72581
D
Common Stock
2018-11-07
4
S
0
700
83.8629
D
71881
D
Common Stock
2018-11-07
4
S
0
13916
84.9995
D
57965
D
Common Stock
2018-11-07
4
S
0
18477
85.4928
D
39488
D
Common Stock
2018-11-07
4
S
0
3781
86.6086
D
35707
D
Common Stock
2018-11-07
4
S
0
100
88.59
D
35607
D
Common Stock
2018-11-07
4
S
0
69
89.60
D
35538
D
Employee Stock Option (right to buy) Holding
27.00
2018-11-07
4
M
0
36633
0.00
D
2026-02-16
Common Stock
36633
20567
D
Employee Stock Option (right to buy) Holding
27.48
2018-11-07
4
M
0
6867
0.00
D
2027-01-31
Common Stock
6867
49253
D
Includes an aggregate of 18,734 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 7, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $80.00 to $80.90.
Represents weighted average sale price. Actual sale prices ranged from $81.00 to $81.70.
Represents weighted average sale price. Actual sale prices ranged from $82.00 to $82.96.
Represents weighted average sale price. Actual sale prices ranged from $83.04 to $84.00.
Represents weighted average sale price. Actual sale prices ranged from $84.25 to $85.11.
Represents weighted average sale price. Actual sale prices ranged from $85.25 to $86.00.
Represents weighted average sale price. Actual sale prices ranged from $86.50 to $86.87.
Represents actual sale price.
The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2018-11-09